Breaking News, Collaborations & Alliances

Chiltern, Karolinska Development Enter Strategic Partnership

Seeks to develop innovative products to sell or out-license

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Chiltern International Ltd. has entered into a partnership with Karolinska Development in Sweden, a life science investment company, to develop innovations, using world-class science, into products that can be sold or out-licensed with the goal of high returns.   “We are extremely pleased to be selected as the partner CRO for Karolinska Development after an extensive CRO selection process in 2012. We were selected based on our compatibility with Karolinska Development’s specific deve...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters